INS and diabetes mellitus: Increase of TNF-α content under the condition of DM can interfere with the insulin signalling pathway, particularly by inhibiting the tyrosine phosphorylation of the insulin receptor and insulin receptor substrate-1 (IRS-1) in adipocytes.